JP Patent

JP7832161B2 — 抗真菌特性を有する局所用ロフルミラスト製剤

Assigned to アーキュティス・バイオセラピューティクス・インコーポレーテッド · Expires 2026-03-17 · 0y expired

What this patent protects

Patent listed against Daliresp.

Drugs covered by this patent

Patent Metadata

Patent number
JP7832161B2
Jurisdiction
JP
Classification
—
Expires
2026-03-17
Drug substance claim
No
Drug product claim
No
Assignee
アーキュティス・バイオセラピューティクス・インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.